Cellectis files clinical trial application for UCART19 in leukaemia
4 January 2016 | By Victoria White
UCART19 is a potential best-in-class allogeneic Talen gene edited T-cell product for treatment of CD19 expressing haematological malignancies...
List view / Grid view
4 January 2016 | By Victoria White
UCART19 is a potential best-in-class allogeneic Talen gene edited T-cell product for treatment of CD19 expressing haematological malignancies...
23 December 2015 | By Molecular Devices
Run 3D cellular assays with confocal results – at a speed you’d only expect from widefield screening, with Molecular Devices’ new confocal HCS system...
15 December 2015 | By Victoria White
There are thought to be as many as 600,000 protein-protein interactions that could be targets for new drugs. The project seeks to analyse and categorise the important features of these interactions...
15 December 2015 | By Victoria White
The "Takeda-CiRA Joint Programme for iPS Cell Applications" (T-CiRA) will begin research in six core directions to explore clinical applications of stem cells in therapeutic areas including cancer, heart failure and diabetes mellitus...
11 December 2015 | By Victoria White
The study will look at the safety and tolerability of PnuBioVax for three different dosages against the bacterial pathogen Streptococcus pneumoniae...
8 December 2015 | By Victoria White
Doctors are harnessing patients’ own immune systems in a pioneering trial taking place in London in an effort to find a new effective treatment for resistant head and neck cancer...
The success story of Mapp Pharmaceuticals’ experimental drug, ZMapp, during last year’s Ebola outbreak highlights the potential of plant-made monoclonal antibodies (mAbs) as life-saving treatments.
1 December 2015 | By Victoria White
With Universal Cells’ proprietary gene editing technology, Adaptimmune intends to develop affinity enhanced donor T-cells...
30 November 2015 | By Victoria White
This groundbreaking development could help advance a variety of liver-related research and applications...
23 November 2015 | By Victoria White
Using bone samples from people undergoing hip replacement surgery, researchers were able to show that a drug that activates the Wnt pathway causes stem cells found within bones to divide and to turn into more bone cells...
17 November 2015 | By Victoria White
A new study is the first to show that Duchenne muscular dystrophy directly affects muscle stem cells...
4 November 2015 | By Victoria White
Scientists have developed a 3-D printing method capable of producing highly uniform embryoid body that could eventually be used for tissue regeneration...
26 October 2015 | By Victoria White
The US 9,181,527 Celyad Allogeneic Patent significantly strengthens Celyad’s patent portfolio in the CAR T-Cell field...
23 October 2015 | By Victoria White
The work paves the way for personalised drug discovery for kidney disease...
23 October 2015 | By Victoria White
Using iPSC technology, researchers created 16 different cells lines, some using cells from healthy humans and others using cells from people with ALS or spinal muscular atrophy...